Elicio Therapeutics, Inc.
USD4.00
+0.25 (+6.67%)
CEO
Robert T. Connelly
IPO Date
2021-02-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.72
Prev. Close
$3.75
Day Low
$3.63
Day High
$4.10
52W Low
$2.66
52W High
$16.00
Market Cap
$0.08B
Volume
2.19M
| 147,200 |
| $8.10 |
| 3 Feb 2026 | Shah Preetam | See Remarks | A-Award | Acquired | 47,900 | $8.10 |
| 3 Feb 2026 | Shah Preetam | See Remarks | A-Award | Acquired | 24,000 | $0.00 |
| 3 Feb 2026 | DeMuth Peter | Chief Scientific Officer | A-Award | Acquired | 20,800 | $0.00 |
| 3 Feb 2026 | DeMuth Peter | Chief Scientific Officer | A-Award | Acquired | 41,600 | $8.10 |
| 3 Feb 2026 | Haqq Christopher | See Remarks | A-Award | Acquired | 25,400 | $0.00 |
| 3 Feb 2026 | Haqq Christopher | See Remarks | A-Award | Acquired | 50,900 | $8.10 |
| 10 Dec 2025 | DeMuth Peter | Chief Scientific Officer | M-Exempt | Acquired | 362 | $4.41 |
| 10 Dec 2025 | DeMuth Peter | Chief Scientific Officer | M-Exempt | Disposed | 362 | $4.41 |